Broad spectrum antibiotics prescribing among patients with hepatocellular carcinoma undergoing radiofrequency ablation or transcatheter arterial chemoembolization
碩士 === 高雄醫學大學 === 公共衛生學系公共衛生學碩士班 === 105 === Background and Objective: Whether transcatheter arterial (chemo)embolization [TA(C)E] or radiofrequency ablation (RFA) carries the risk of infection. The issue of prophylactic antibiotic agents before and after the procedure is controversial. Fever often...
Main Authors: | Yi-Chun Chen, 陳怡君 |
---|---|
Other Authors: | Chun-Yuh Yang |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/59065098213988733333 |
Similar Items
-
Effect of sorafenib combined with transcatheter arterial chemoembolization and radiofrequency ablation on the survival of patients with hepatocellular carcinoma
by: SUN Bin
Published: (2019-01-01) -
Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors.
by: Mi Hye Yu, et al.
Published: (2019-01-01) -
Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas
by: Tai-Yang Zuo, et al.
Published: (2017-01-01) -
Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation
by: Shen Y, et al.
Published: (2019-09-01) -
Fusion imaging-guided radiofrequency ablation for residual hepatocellular carcinoma invisible on ultrasound after transcatheter arterial chemoembolization
by: Jiong-Hui Gu, et al.
Published: (2021-01-01)